Jazz Pharmaceuticals plcJAZZ

Where JAZZ's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$246.81-0.76 (-0.31%)Previous close
NASDAQHealthcare

JAZZ Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
JAZZ Net Debt / EBITDA historyJAZZ Net Debt / EBITDA from Sep 2023 to Jun 2026: low 1.89, high 28.99, latest 1.89.-0.287.5815.4423.331.15Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 3.17

JAZZ Net Debt / EBITDA by year

Yearly range of JAZZ’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.1 to 29.0, averaging 3.8.

JAZZ Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20261.94.26.61.9
20252.714.429.029.0
20242.63.03.32.6
20233.13.23.43.1
20223.44.05.03.6
20210.14.97.25.4
20201.11.31.51.1
20190.91.11.21.1
20181.31.41.51.4
20171.51.82.01.5
20162.22.42.52.2

Get notified when JAZZ Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.